Sale by Chadwick Jeremy G (Chief Operating Officer)
17,184 shares · @ $79.92 · $1,373,290
Kymera Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $78.47
-0.3% in 1d after detection
Post-detection moves
1h
—
1d
-0.3%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS